A retrospective observational analysis to evaluate the off-label use of bevacizumab alone or with irinotecan in recurrent glioblastoma

Author: Cecchi Michele  

Publisher: Springer Publishing Company

ISSN: 2210-7703

Source: International Journal of Clinical Pharmacy, Vol.35, Iss.3, 2013-06, pp. : 483-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract